NCT04725916 Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
| NCT ID | NCT04725916 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sean Devitt |
| Condition | Postoperative Wound Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-02-23 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-02-23 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective randomized, controlled, unblinded, interventional feasibility study to evaluate if showering with post operative drains in place leads to an increase in complications. The patients included in the study will be those undergoing breast reductions and panniculectomies at Geisinger Medical Center. The patients will be randomized post operatively into one of two groups: 1) patients instructed to shower with drains in place, and 2) patients instructed not to shower while they have drains in place.
Eligibility Criteria
Inclusion Criteria: * Patients having one of the following procedures at Geisinger Medical Center in which drains are placed * Breast reduction * Lower panniculectomy * Fleur-de-lis panniculectomy * ≥18 years of age * Able and willing to provide consent Exclusion Criteria: * Patients on antibiotics at the time of surgery * Patients sent home on antibiotics after surgery * Patients who work in healthcare with direct patient contact * Patients having a panniculectomy to be eligible for a kidney transplant * Patients having a ventral hernia repair at the time of the panniculectomy * Patients admitted to the hospital for \>1 night
Contact & Investigator
Sean Devitt, MD
PRINCIPAL INVESTIGATOR
Geisinger Clinic
Frequently Asked Questions
Who can join the NCT04725916 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Wound Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04725916 currently recruiting?
Yes, NCT04725916 is actively recruiting participants. Contact the research team at sdevitt@geisinger.edu for enrollment information.
Where is the NCT04725916 trial being conducted?
This trial is being conducted at Danville, United States.
Who is sponsoring the NCT04725916 clinical trial?
NCT04725916 is sponsored by Sean Devitt. The principal investigator is Sean Devitt, MD at Geisinger Clinic. The trial plans to enroll 100 participants.